Asia Pacific

Credit: NUS

NUS spin-off company develops one-minute breath test to detect COVID-19
Breathonix’s breath analysis technology works by detecting Volatile Organic Compounds (VOCs) present in a person’s exhaled breath.
Singapore and Apple partner on national health initiative called LumiHealth
Malaysia’s HealthMetrics scores $5M in Series A funding
Learn on-demand, earn credit, find products and solutions. Get Started >>

Regional News

Omron, HeartVoice & Great Eastern launch new program to encourage healthy living
October 29, 2020
Savonix launches Japanese website as part of international expansion
October 26, 2020
Doctor Anywhere launches online mental health consultation service
October 20, 2020
Developer of Temp Pal smart thermometer scores additional $2.4M in Pre-Series A round
September 29, 2020
Infocom announces strategic investment in caregiving and telehealth startup Homage
September 24, 2020
Health2Sync partners with Sanofi to deliver a digital solution for diabetes patients & care providers
September 16, 2020
Singapore to distribute TraceTogether token nationwide from mid-September
September 09, 2020
Singapore launches first nationwide collaborative ecosystem for cancer care
September 09, 2020

More Regional News

Global News

More Global News
HIMSS chapters prioritizing the elimination of health disparities
By HIMSS TV
October 30, 2020
A woman massages her sore back
Evaluating musculoskeletal digital health apps
By Dr. Liz Kwo
October 30, 2020
Dr. Sumbul Desai, Apple's VP of Health, presents the new Apple Watch blood oxygenation sensor at an event in September.
Apple collaborates with researchers on studies of heart failure, flu
By Jonah Comstock
October 30, 2020

Special Projects

Building a Solid Foundation for Transformation
Focusing on privacy and security in the coronavirus new normal
Nurse in mask using a computer.
Population health management enters an uncharted new era
Population illustration
How stakeholders are separating the hype from the real deal
Digital health developments in 2020 and beyond: What to expect
Focus on: The Future of Pharma